ASCO 2016 | Targeted therapy for advanced solid tumors based on molecular profiles: early results from MyPathway
Press brief by John Hainsworth, MD of the Sarah Cannon Research Institute, Nashville, TN, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
Get great new content delivered to your inboxSign up
COVID-19 experience in Swirzerland
The treatment of BC brain metastases
Endocrine therapy in premenopausal women with HR+ breast cancer
The role of surgery in metastatic breast cancer
Designing innovative clinical trials in BC